NCT01580891View on ClinicalTrials.gov

Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis

PHASE1CompletedINTERVENTIONAL
Enrollment

1,053

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2013

Conditions
Tinea Pedis
Interventions
DRUG

Naftifine HCl Cream 1%

Naftifine HCl Cream 1% applied topically once a day for 28 days.

DRUG

Naftin® (Naftifine HCl) Cream 1%

Naftin® (Naftifine HCl) Cream 1% applied topically once a day for 28 days.

DRUG

Placebo topical cream

Placebo topical cream applied topically once a day for 28 days.

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT01580891 - Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis | Biotech Hunter | Biotech Hunter